Steven R. Johnson

Corporate Officer/Principal presso Laureate Biopharmaceutical Services, Inc.

Consumer Services

Health Technology

Profilo

Steven R.
Johnson is currently the Vice President of Business Development at Laureate Biopharmaceutical Services, Inc. He holds a Master's in Business Administration from James Madison University and an undergraduate degree from the University of Illinois.

Posizioni attive di Steven R. Johnson

Società	Posizione	Inizio
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Corporate Officer/Principal	29/09/2010

Tutte le posizioni attive di Steven R. Johnson

Formazione di Steven R. Johnson

University of Illinois	Undergraduate Degree
James Madison University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Steven R. Johnson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Health Technology